Advertisement

Topics

Claris Lifesciences Inc Company Profile

20:20 EDT 17th June 2018 | BioPortfolio

Claris is our endeavor to help preserve earth’s most precious resource... Vision
To be, one of the worlds’s leading and most admired pharmaceutical companies in the global Generics industry.
To continually create value and bring pride, to, our stakeholders, partners, customers and the community at large.
To preserve earth’s most precious resource… human lives.
Mission
A world-class organization, built on,

• Outstanding performance led by Entrepreneurial culture.
• Product quality through Emotional Pharmacopoeia.
• Management capability, Efficient processes and Technology.
• Youth, hard work and discipline.

Achieved in a manner of fairness, honesty and corporate responsibility.

Location

542 Industrial Way West
Eastontown
New Jersey
7724
United States of America

Contact

Phone: 1 732 713 0978
Email: claris@clarislifesciences.com


News Articles [83 Associated News Articles listed on BioPortfolio]

Edwards Lifesciences Corp (EW) VP Sells $762,300.00 in Stock

Edwards Lifesciences Corp VP Larry L. Wood sold 6,300 shares of Edwards Lifesciences stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $121.00, for a tota...

Insider Selling: Edwards Lifesciences Corp (EW) CFO Sells 25,000 Shares of Stock

Edwards Lifesciences Corp CFO Scott B. Ullem sold 25,000 shares of Edwards Lifesciences stock in a transaction dated Wednesday, April 4th. The stock was sold at an average price of $137.17, for a tota...

Head-To-Head Contrast: Edwards Lifesciences

Edwards Lifesciences and Wright Medical Group are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earni...

Edwards Lifesciences Corp. Earnings Rise In Q4

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) announced a profit for its fourth quarter that rose compared to the same period last year.The company said its bottom line totaled $203.1 mil...

$400M share repurchasing deal reached by Edwards Lifesciences

An agreement to buy back $400 million in common shares was reached by Edwards Lifesciences, which will receive about 2.5 mill -More- 

Study shows promising results for Edwards Lifesciences' heart valve

A study in the Journal of the American College of Cardiology found that use of Edwards Lifesciences' Centera transcatheter he -More- 

ReShape Lifesciences announces cost-reduction, integration efforts

ReShape Lifesciences announced plans to implement an operating expenses reduction of about 25%, bringing its monthly expendit -More- 

Edwards Lifesciences Corp. Q1 adjusted earnings Beat Estimates

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) reported a profit for first quarter that declined from last year.The company's earnings totaled $206.6 million, or $0.96 per share. This comp...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Claris [Stratus Pharamceuticals, Inc]

CLARIS™ CLARIFYING WASH

Fluconazole [Claris Lifesciences Inc.]

Fluconazole Injection For Intravenous Use OnlyRx only

Metronidazole [Claris Lifesciences Inc.]

Metronidazole Injection, USP

Ampicillin [Claris Lifesciences, Inc.]

Ampicillin for Injection, USP for Intramuscular or Intravenous Injection Rx only

Ondansetron hydrochloride and dextrose [Claris Lifesciences, Inc]

Ondansetron in 5% Dextrose Injection

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Goal-Directed Fluid Resuscitation Protocol Based on Arterial Waveform Analysis of Major Burn Patients in a Mass Burn Casualty.

Adequate fluid titration during the initial resuscitation period of major burn patients is crucial. This study aimed to evaluate the feasibility and efficacy of a goal-directed fluid resuscitation pro...

Randomized trial of the Carpentier-Edwards supra-annular prosthesis versus the Medtronic Mosaic aortic prosthesis: 10-year results.

We performed a prospective randomized study comparing the clinical performance of the Carpentier-Edwards supra-annular valve (CE-SAV) (Edwards Lifesciences, Irvine, CA, USA) and the newer Mosaic (Medt...

Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis.

Current retrospective evidence suggests similar clinical and superior hemodynamic outcomes of the Sorin Freedom Solo stentless aortic valve (SFS) (LivaNova PLC, London, UK) compared to the Carpentier ...

The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.

We report the first successful valve-in-valve (ViV) implantation into a failed Edwards Biophysio surgical prosthesis (Edwards Lifesciences, Irvine, CA) and also the first use of the J-Valve system (Ji...

Clinical Trials [19 Associated Clinical Trials listed on BioPortfolio]

Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population

To evaluate the safety and effectiveness of the SAPIEN XT (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic seve...

Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) in the Chinese Population

To evaluate the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic sever...

Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Replacement (TMVR) Early Feasibility Study

Early feasibility study to evaluate the safety and function of the Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve

Hemodynamic Optimization During Major Abdominal Surgery

In this prospective observational study investigators aim to search any relationship between the venous to arterial carbon dioxide gap and the time of percentage to adherence too a stroke ...

The PARTNER 3 - AVIV Trial

To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing aortic bioprosthetic valve.

Companies [28 Associated Companies listed on BioPortfolio]

Claris Lifesciences Inc

Claris is our endeavor to help preserve earth’s most precious resource... Vision To be, one of the worlds’s leading and most admired pharmaceutical companies in the global Generics industry.To con...

Vedic Lifesciences Pvt. Ltd.

Vedic Lifesciences, a Phase II/III CRO, also undertakes project management of Pre-Clinical Development Services for Pharma and Biotech Companies. We have an in-house team for Medical Affairs, Regulato...

Solace Lifesciences

Solace Lifesciences, the creators of NuCalm, is a pioneer in the fields of applied neuropsychobiology and bioinformatics. Founded in 2002, the company is dedicated to improving th...

LifeSciences BC

LifeSciences BC is a not-for-profit, non-government industry association that represents and supports the biopharmaceutical, medical device, bioproducts, bioenergy and greater lif...

Edwards Lifesciences

Edwards Lifesciences Global Headquarters is located in Irvine, California, U.S.A. Our company supplies products and technologies to customers in more than 100 countries, through both direct sales and...

More Information about "Claris Lifesciences Inc" on BioPortfolio

We have published hundreds of Claris Lifesciences Inc news stories on BioPortfolio along with dozens of Claris Lifesciences Inc Clinical Trials and PubMed Articles about Claris Lifesciences Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Claris Lifesciences Inc Companies in our database. You can also find out about relevant Claris Lifesciences Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record